Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0000950170-25-046368
Filing Date
2025-03-28
Accepted
2025-03-28 10:48:15
Documents
79
Period of Report
2025-01-31

Document Format Files

Seq Description Document Type Size
1 6-K ipa-20250131.htm   iXBRL 6-K 288675
2 EX-99.1 ipa-ex99_1.htm EX-99.1 757490
3 EX-99.2 ipa-ex99_2.htm   iXBRL EX-99.2 2829227
4 EX-99.3 ipa-ex99_3.htm EX-99.3 26217
5 EX-99.4 ipa-ex99_4.htm EX-99.4 25429
6 GRAPHIC img36100363_0.jpg GRAPHIC 24315
7 GRAPHIC img37023884_0.jpg GRAPHIC 24315
  Complete submission text file 0000950170-25-046368.txt   15863781

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT ipa-20250131.xsd EX-101.SCH 1448930
82 EXTRACTED XBRL INSTANCE DOCUMENT ipa-20250131_htm.xml XML 4413248
Mailing Address INDUSTRIOUS, 823 CONGRESS AVE, SUITE 300 AUSTIN TX 78701
Business Address INDUSTRIOUS, 823 CONGRESS AVE, SUITE 300 AUSTIN TX 78701 6048060626
ImmunoPrecise Antibodies Ltd. (Filer) CIK: 0001715925 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0430
Type: 6-K | Act: 34 | File No.: 001-39530 | Film No.: 25781892
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)